Top Strike Resources Corp. (VENI.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -767.99 Thousand CAD | -56.8% |
| 2022 | -631.08 Thousand CAD | -40.33% |
| 2021 | -495.7 Thousand CAD | -20.83% |
| 2020 | -1.23 Million CAD | 85.16% |
| 2019 | 506.98 Thousand CAD | 8.8% |
| 2018 | -1.91 Million CAD | -10159.85% |
| 2017 | 538.00 CAD | 71.63% |
| 2016 | 1075.00 CAD | -239.0% |
| 2015 | 1755.00 CAD | 3.66% |
| 2014 | -20.38 Thousand CAD | 78.11% |
| 2013 | -102.59 Thousand CAD | -19.79% |
| 2012 | -85.64 Thousand CAD | -5.83% |
| 2011 | -80.92 Thousand CAD | -535.63% |
| 2010 | 18.57 Thousand CAD | 112.14% |
| 2009 | -153.04 Thousand CAD | 4.82% |
| 2008 | -160.79 Thousand CAD | 49.08% |
| 2007 | -315.77 Thousand CAD | 51.22% |
| 2006 | -647.39 Thousand CAD | -23.09% |
| 2005 | -953.03 Thousand CAD | -147.82% |
| 2004 | -795.06 Thousand CAD | 345.27% |
| 2003 | -821.23 Thousand CAD | 13.72% |
| 2002 | -519.78 Thousand CAD | 48.28% |
| 2001 | -1 Million CAD | -15.02% |
| 2000 | -873.84 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -206.78 Thousand CAD | -259.37% |
| 2023 FY | - CAD | -56.8% |
| 2023 Q2 | -57.54 Thousand CAD | -37.1% |
| 2023 Q1 | -41.96 Thousand CAD | 46.62% |
| 2022 Q2 | -204.99 Thousand CAD | -49.67% |
| 2022 Q3 | -69.19 Thousand CAD | 66.25% |
| 2022 Q4 | -78.62 Thousand CAD | -13.63% |
| 2022 Q1 | -136.97 Thousand CAD | 6.71% |
| 2022 FY | - CAD | -40.33% |
| 2021 Q2 | -134.92 Thousand CAD | -404.88% |
| 2021 Q4 | -146.82 Thousand CAD | -31.64% |
| 2021 Q1 | 44.25 Thousand CAD | 113.28% |
| 2021 Q3 | -111.53 Thousand CAD | 17.33% |
| 2021 FY | - CAD | -20.83% |
| 2020 Q3 | -46.01 Thousand CAD | 27.14% |
| 2020 Q4 | -333.35 Thousand CAD | -624.45% |
| 2020 Q1 | -39.18 Thousand CAD | 96.23% |
| 2020 Q2 | -63.15 Thousand CAD | -61.17% |
| 2020 FY | - CAD | 85.16% |
| 2019 Q1 | -289.52 Thousand CAD | 82.05% |
| 2019 Q2 | -341.98 Thousand CAD | -18.12% |
| 2019 Q3 | -247.97 Thousand CAD | 27.49% |
| 2019 Q4 | -1.03 Million CAD | -318.7% |
| 2019 FY | - CAD | 8.8% |
| 2018 Q2 | -285.85 Thousand CAD | -8287.79% |
| 2018 Q4 | -1.61 Million CAD | -591.97% |
| 2018 FY | - CAD | -10159.85% |
| 2018 Q1 | -3408.00 CAD | 67.88% |
| 2018 Q3 | -233.06 Thousand CAD | 18.47% |
| 2017 Q3 | -3237.00 CAD | -12.91% |
| 2017 FY | - CAD | 71.63% |
| 2017 Q1 | -4094.00 CAD | 74.23% |
| 2017 Q2 | -2867.00 CAD | 29.97% |
| 2017 Q4 | -10.6 Thousand CAD | -227.74% |
| 2016 Q1 | -4102.00 CAD | 61.66% |
| 2016 FY | - CAD | -239.0% |
| 2016 Q2 | -40.19 Thousand CAD | -879.94% |
| 2016 Q3 | -13.16 Thousand CAD | 67.24% |
| 2016 Q4 | -15.88 Thousand CAD | -20.67% |
| 2015 Q1 | -5245.00 CAD | 52.13% |
| 2015 Q4 | -10.69 Thousand CAD | -374.41% |
| 2015 FY | - CAD | 3.66% |
| 2015 Q2 | -3446.00 CAD | 34.3% |
| 2015 Q3 | -2255.00 CAD | 34.56% |
| 2014 Q2 | -4500.00 CAD | -8.83% |
| 2014 Q1 | -4135.00 CAD | 88.47% |
| 2014 FY | - CAD | 78.11% |
| 2014 Q3 | -3080.00 CAD | 31.56% |
| 2014 Q4 | -10.95 Thousand CAD | -255.71% |
| 2013 Q4 | -35.86 Thousand CAD | -79.33% |
| 2013 Q3 | -19.99 Thousand CAD | 3.56% |
| 2013 Q2 | -20.73 Thousand CAD | 20.25% |
| 2013 Q1 | -26 Thousand CAD | -5.37% |
| 2013 FY | - CAD | -19.79% |
| 2012 Q3 | -28.57 Thousand CAD | -0.49% |
| 2012 Q4 | -24.67 Thousand CAD | 13.63% |
| 2012 Q1 | -3972.00 CAD | 86.86% |
| 2012 FY | - CAD | -5.83% |
| 2012 Q2 | -28.43 Thousand CAD | -615.79% |
| 2011 Q2 | -11.86 Thousand CAD | 50.95% |
| 2011 Q4 | -30.21 Thousand CAD | -135.92% |
| 2011 FY | - CAD | -535.63% |
| 2011 Q1 | -24.17 Thousand CAD | -153.16% |
| 2011 Q3 | -12.8 Thousand CAD | -8.0% |
| 2010 Q2 | -49.71 Thousand CAD | 22.8% |
| 2010 Q3 | -24.5 Thousand CAD | 50.7% |
| 2010 Q4 | -9550.00 CAD | 61.03% |
| 2010 FY | - CAD | 112.14% |
| 2010 Q1 | -64.39 Thousand CAD | -214.72% |
| 2009 Q4 | -20.46 Thousand CAD | 65.61% |
| 2009 FY | - CAD | 4.82% |
| 2009 Q1 | -32.06 Thousand CAD | -238.9% |
| 2009 Q3 | -59.5 Thousand CAD | -45.06% |
| 2009 Q2 | -41.01 Thousand CAD | -27.93% |
| 2008 Q4 | -9461.00 CAD | 88.28% |
| 2008 FY | - CAD | 49.08% |
| 2008 Q2 | -26.81 Thousand CAD | 59.39% |
| 2008 Q3 | -80.73 Thousand CAD | -201.11% |
| 2008 Q1 | -66.01 Thousand CAD | 5.13% |
| 2007 Q4 | -69.59 Thousand CAD | 10.67% |
| 2007 FY | - CAD | 51.22% |
| 2007 Q3 | -77.9 Thousand CAD | 0.0% |
| 2006 FY | - CAD | -23.09% |
| 2005 Q1 | -213.01 Thousand CAD | 45.97% |
| 2005 Q3 | -61.79 Thousand CAD | 51.58% |
| 2005 Q2 | -127.61 Thousand CAD | 40.09% |
| 2005 Q4 | -289.06 Thousand CAD | -367.79% |
| 2005 FY | - CAD | -147.82% |
| 2004 Q4 | -394.25 Thousand CAD | -316.88% |
| 2004 FY | - CAD | 345.27% |
| 2004 Q3 | -94.57 Thousand CAD | 15.57% |
| 2004 Q2 | -112.01 Thousand CAD | 42.33% |
| 2004 Q1 | -194.21 Thousand CAD | -683.33% |
| 2003 Q2 | -141.98 Thousand CAD | -59.49% |
| 2003 FY | - CAD | 13.72% |
| 2003 Q4 | -349.23 Thousand CAD | 90.86% |
| 2003 Q3 | -271.29 Thousand CAD | -189.7% |
| 2003 Q1 | -58.71 Thousand CAD | 29.27% |
| 2002 Q4 | -169.22 Thousand CAD | 16.09% |
| 2002 Q1 | -41.8 Thousand CAD | 67.27% |
| 2002 Q2 | -65.54 Thousand CAD | -56.81% |
| 2002 Q3 | -140.19 Thousand CAD | -50.94% |
| 2002 FY | - CAD | 48.28% |
| 2001 Q2 | -66.57 Thousand CAD | 53.95% |
| 2001 Q1 | -144.56 Thousand CAD | -17.43% |
| 2001 FY | - CAD | -15.02% |
| 2001 Q3 | -124.88 Thousand CAD | -87.6% |
| 2001 Q4 | -127.72 Thousand CAD | -2.28% |
| 2000 Q1 | -274.66 Thousand CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| 2000 Q4 | -123.11 Thousand CAD | 69.45% |
| 2000 Q3 | -403 Thousand CAD | -70.82% |
| 2000 Q2 | -235.92 Thousand CAD | 14.1% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 87.355% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 61.801% |
| Blueberries Medical Corp. | -1.22 Million CAD | 37.142% |
| The BC Bud Corporation | -1.19 Million CAD | 35.787% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 88.157% |
| CordovaCann Corp. | -1.6 Million CAD | 52.079% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 70.726% |
| Captor Capital Corp. | 2.42 Million CAD | 131.72% |
| City View Green Holdings Inc. | -2.01 Million CAD | 61.876% |
| 1CM Inc. | 1.31 Million CAD | 158.468% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -2997.62% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 65.224% |
| IM Cannabis Corp. | -2.79 Million CAD | 72.473% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 82.555% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -95.809% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 75.948% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 167.273% |
| Ovation Science Inc. | -778.83 Thousand CAD | 1.392% |
| Pharmadrug Inc. | -1.33 Million CAD | 42.473% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 87.319% |
| RAMM Pharma Corp. | -6.3 Million CAD | 87.814% |
| RIV Capital Inc. | -20.28 Million CAD | 96.213% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 86.274% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 99.01% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 73.973% |
| 1933 Industries Inc. | -10.03 Million CAD | 92.345% |
| Red Light Holland Corp. | -5.25 Million CAD | 85.388% |
| Xebra Brands Ltd. | -1.49 Million CAD | 48.629% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 45.581% |